Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Nantes University Hospital
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Number of predictive factors for exacerbation outcome in severe asthmatics.
Study Overview
Brief Summary
Asthma is a chronic inflammatory disease, affecting up to 10 % of the general population in developed countries. Corticosteroids are necessary to control symptoms, but induce adverse events sometimes intolerable. In severe asthma, which represent 5 to 10% of global asthma, corticosteroids frequently fail to prevent severe exacerbations, leading to emergency care, hospitalization and sometimes death. The aim of this study is to identify predictive factors specific for exacerbation outcome which will lead to a minor increase in treatment in order to prevent exacerbations, while minimizing drug adverse effects.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of predictive factors for exacerbation outcome in severe asthmatics.
Secondary Outcomes
- Rate of predictive factors identified in the study, in order to prevent exacerbations.
